GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » ROE % Adjusted to Book Value

Vicplas International (SGX:569) ROE % Adjusted to Book Value : 0.62% (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Vicplas International ROE % Adjusted to Book Value?

Vicplas International's ROE % for the quarter that ended in Jan. 2024 was 0.58%. Vicplas International's PB Ratio for the quarter that ended in Jan. 2024 was 0.93. Vicplas International's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2024 was 0.62%.


Vicplas International ROE % Adjusted to Book Value Historical Data

The historical data trend for Vicplas International's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International ROE % Adjusted to Book Value Chart

Vicplas International Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.58 7.09 10.68 9.28 5.68

Vicplas International Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.08 7.87 5.09 4.67 0.62

Competitive Comparison of Vicplas International's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Vicplas International's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicplas International's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Vicplas International's ROE % Adjusted to Book Value falls into.



Vicplas International ROE % Adjusted to Book Value Calculation

Vicplas International's ROE % Adjusted to Book Value for the fiscal year that ended in Jul. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.40% / 0.95
=5.68%

Vicplas International's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.58% / 0.93
=0.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicplas International ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Vicplas International's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicplas International (SGX:569) Business Description

Traded in Other Exchanges
N/A
Address
35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines